According to the new 2024 ACR Guidelines for Lupus Nephritis, How Should You Screen and Diagnose LN in Your SLE Patients?

Monica Richey, NP, a seasoned rheumatology specialist with two decades of experience, provides an in-depth review of the 2024 lupus nephritis screening and diagnosis guidelines. As systemic lupus erythematosus (SLE) remains a leading cause of kidney-related complications, early detection and accurate diagnostic methods are essential for improving patient outcomes.

This expert-led discussion explores the latest best practices for lupus nephritis screening, emphasizing why the spot protein-to-creatinine ratio has become the preferred diagnostic tool over the traditional 24-hour urine collection. The shift aims to provide a more efficient and practical approach to identifying early kidney involvement in SLE patients. Monica highlights the importance of performing full urinalysis at every patient visit, a practice that allows for earlier intervention and better disease management.

The discussion also covers when healthcare providers should consider a kidney biopsy to confirm a lupus nephritis diagnosis and determine disease severity. Understanding lupus nephritis classifications and chronicity is crucial for tailoring treatment strategies and preventing long-term kidney damage. Monica shares her real-world insights on proactive patient care, offering guidance on how frequent monitoring can lead to more effective disease control.

For rheumatology professionals, nephrologists, and caregivers, this video provides a comprehensive overview of the evolving landscape of lupus nephritis diagnosis. By staying informed on the latest screening recommendations, healthcare providers can enhance their approach to patient care and contribute to improved outcomes in lupus management.

For more expert discussions on the latest advancements in rheumatology, visit RhAPP.org or explore the RhAPP ACE App.